An exploratory survey on the views of european tissue engineers concerning the ethical issues of tissue engineering research

Tissue Engineering - Part B: Reviews

Volumn 15, Issue 3, 2009, Pages 241-247

  Trommelmans, Leen ^a,b   Selling, Joseph ^a   Dierickx, Kris ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Centre for Biomedical Ethics and Law   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; ENGINEERED PRODUCTS; ETHICAL ISSUES; HUMAN TISSUES; TISSUE ENGINEERS; UNIQUE FEATURES;

SURVEYS; TISSUE;

TISSUE ENGINEERING;

ARTICLE; E-MAIL; EUROPE; HEALTH SURVEY; MEDICAL RESEARCH; MEDICAL SPECIALIST; PRIORITY JOURNAL; PROFESSIONAL STANDARD; QUESTIONNAIRE; RESEARCH ETHICS; SCIENTIST; TISSUE ENGINEERING;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; DATA COLLECTION; ETHICS, MEDICAL; EUROPE; FEMALE; HUMANS; MALE; TISSUE ENGINEERING;

EID: 69949173320     PISSN: 19373368     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.teb.2008.0647     Document Type: Article

References (29)

1. The European Parliament and the Council of the European Union. Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004. Official Journal of the European Union, L 324/121, 2007. Available at http://eur-lex.europa.eu/LexUriServ/LexUriServ .do?uri=OJ:L:2007:324:0121:0137:EN:PDF. Accessed February 20, 2009.
2. Trommelmans, L., Selling, J., and Dierickx, K. Ethical issues in tissue engineering, European ethical-legal papers no 7. Leuven: Centre for biomedical ethics and law; 2007. Available at www.cbmer.be. Accessed February 20, 2009.
3. European Group on Ethics. Report of the European group on Ethics on the ethical aspects of human tissue engineered products. Brussels; 2004. Available at http://ec.europa .eu/european-group-ethics/docs/humantissueprod-en.pdf. Accessed February 20, 2009.
4. De Vries, R.B., Oerlemans, A., Trommelmans, L., Dierickx, K., and Gordijn, B. Ethical aspects of tissue engineering: a review. Tissue Eng Part B Rev 14, 367, 2008.
5. Ebbesen, M., and Jensen, T.G. Nanomedicine: techniques, potentials, and ethical implications. J Biomed Biotechnol 2006, 51516, 2006.
6. 6. Longley, D., and Lawford, P. Engineering human tissue and regulation: confronting biology and law to bridge the gaps. Med Law Int 5, 101, 2001. (Pubitemid 33318646)
7. 7. Mazhari, R., and Hare, J.M. Advances in cell-based therapy for structural heart disease. Prog Cardiovasc Dis 49, 387, 2007. (Pubitemid 46693947)
8. 8. Sievert, K.D., Amend, B., and Stenzl, A. Tissue engineering for the lower urinary tract: a review of a state of the art approach. Eur Urol 52, 1580, 2007. (Pubitemid 350052422)
9. Tsang, L. Legal and ethical status of stem cells as medicinal products. Adv Drug Delivery Rev 57, 1970, 2005.
10. Williams, D.F. A registry for tissue engineering clinical trials. Med Device Technol 17, 8, 2006.
11. Yoo, M.Y. Government regulations on cellular therapy and proposed approach related with these products by KFDA. Yonsei Med J 45 Suppl 5, 2004.
12. 12. Faulkner, A., Kent, J., Geesink, I., and FitzPatrick, D. Purity and the dangers of regenerative medicine: regulatory innovation of human tissue-engineered technology. Soc Sci Med 63, 2277, 2006. (Pubitemid 44374821)
13. Baum, B.J., and Mooney, D.J. The impact of tissue engineering on dentistry. J Am Dent Assoc 131, 309, 2000.
14. Hammerman, M.R., and Cortesini, R. Organogenesis and tissue engineering. Transpl Immunol 12, 191, 2004.
15. 15. Pascal, P., Damour, O., Colpart, J.J., and Braye, F. French legal framework relating to human tissues and cells. Med Biol Eng Comput 38, 241, 2000. (Pubitemid 30193001)
16. 16. Sanzenbacher, R., Dwenger, A., Schuessler-Lenz, M., Cichutek, K., and Flory, E. European regulation tackles tissue engineering. Nat Biotechnol 25, 1089, 2007. (Pubitemid 47538102)
17. Satava, R.M. Biomedical, ethical, and moral issues being forced by advanced medical technologies. Proc Am Philos Soc 147, 246, 2003.
18. Schwab, I.R., Johnson, N.T., and Harkin, D.G. Inherent risks associated with manufacture of bioengineered ocular surface tissue. Arch Ophthalmol 124, 1734, 2006.
19. 19. Trommelmans, L., Selling, J., and Dierickx, K. A critical assessment of the directive on tissue engineering of the European union. Tissue Eng 13, 667, 2007. (Pubitemid 46651497)
20. 20. Enoch, S., Shaaban, H., and Dunn, K.W. Informed consent should be obtained from patients to use products (skin substitutes) and dressings containing biological material. J Med Ethics 31, 2, 2005. (Pubitemid 40214687)
21. Trommelmans, L., Selling, J., and Dierickx, K. Ethical reflections on clinical trials with human tissue engineered products. J Med Ethics 34, e1, 2008.
22. The European Parliament and the Council of the European Union, Directive 2001/20/EC of the European Parliament of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practices in the conduct of clinical trials on medicinal products for human use, Official Journal of the European Communities L 121/34, 2001. Available at http://europa .eu/eur-lex/pri/en/oj/dat/2001/l-121/l-12120010501en00340044 .pdf. Accessed February 20, 2009.
23. 23. Daley, G.Q., Ahrlund, R.L., Auerbach, J.M., Benvenisty, N., Charo, R.A., Chen, G., Deng, H., Goldstein, L., Hudson, K., Hyun, I., Junn, S., Love, J., Lee, E., McLaren, A., Mummery, C., Nakatsuji, N., Racowsky, C., Rooke, H., Rossant, J., Schöler, H., Solbakk, J., Taylor, P., Trounson, A., Weissman, I., Wilmut, I., Yu, J., and Zoloth, L. Ethics. The ISSCR guidelines for human embryonic stem cell research. Science 315, 603, 2007. (Pubitemid 46214694)
24. 24. Kent, J., Faulkner, A., Geesink, I., and FitzPatrick, D. Towards governance of human tissue engineered technologies in Europe: framing the case for a new regulatory regime. Technol Forecast Soc Change 73, 41, 2006. (Pubitemid 43115628)
25. Trommelmans, L., Selling, J., and Dierickx, K. Informing participants in clinical trials with ex vivo human tissueengineered products: what to tell and how to tell it? J Tissue Eng Regen Med 2, 236, 2008.
26. National Institute for Clinical Excellence (NICE). The use of autologous chondrocyte implantation for the treatment of cartilage defects in knee joints. Review of Technology appraisal 16. 2005. Report No.: Technology Appraisal 16. Available at http://www.nice.org.uk/nicemedia/pdf/TA089 guidance.pdf. Accessed February 20, 2009.
27. Levine, RJ. Ethics and Regulation of Clinical Research, second edition. Baltimore, MA: Urban and Schwarzenberg, 1986.
28. Daar, A.S., and Greenwood, H.L. A proposed definition of regenerative medicine. J Tissue Eng Regen Med 1, 179, 2007.
29. Kass, N.E., Sugarman, J., Faden, R., and Schoch-Spana, M. Trust, the fragile foundation of contemporary biomedical research. Hastings Cent Rep 26, 25, 1996.